» Articles » PMID: 24019899

Circulating Microparticles from Crohn's Disease Patients Cause Endothelial and Vascular Dysfunctions

Overview
Journal PLoS One
Date 2013 Sep 11
PMID 24019899
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Microparticles (MPs) are small vesicles released during cell activation or apoptosis. They are involved in coagulation, inflammation and vascular dysfunction in several diseases. We characterized circulating MPs from Crohn's Disease (CD) patients and evaluated their effects on endothelial function and vascular reactivity after in vivo injection into mice.

Methods: Circulating MPs and their cellular origins were examined by flow cytometry from blood samples from healthy subjects (HS) and inactive or active CD patients. MPs were intravenously injected into mice. After 24 hours, endothelial function and vascular reactivity were assessed.

Results: Circulating MP levels did not differ between HS and inactive CD patients except for an increase in leukocyte-derived MPs in CD. Active CD patients compared to HS displayed increased total circulating MPs, pro-coagulant MPs and those from platelets, endothelium, erythrocytes, leukocytes, activated leukocytes and activated platelets. A significant correlation was found between total levels of MPs, those from platelets and endothelial cells, and the Harvey-Bradshaw clinical activity index. MPs from CD, but not from HS, impaired endothelium-dependent relaxation in mice aorta and flow-induced dilation in mice small mesenteric arteries, MPs from inactive CD patients being more effective than those from active patients. CDMPs induced vascular hypo-reactivity in aorta that was prevented by a nitric oxide (NO)-synthase inhibitor, and was associated with a subtle alteration of the balance between NO, reactive oxygen species and the release of COX metabolites.

Conclusions: We provide evidence that MPs from CD patients significantly alter endothelial and vascular function and therefore, may play a role in CD pathophysiology, at least by contributing to uncontrolled vascular-dependent intestinal damage.

Citing Articles

Assessment of Extracellular Particles Directly in Diluted Plasma and Blood by Interferometric Light Microscopy. A Study of 613 Human and 163 Canine Samples.

Korenjak B, Tratensek A, Arko M, Romolo A, Hocevar M, Kisovec M Cells. 2025; 13(24.

PMID: 39768146 PMC: 11674815. DOI: 10.3390/cells13242054.


Overcoming donor variability and risks associated with fecal microbiota transplants through bacteriophage-mediated treatments.

Rasmussen T, Mao X, Forster S, Larsen S, Von Munchow A, Tranaes K Microbiome. 2024; 12(1):119.

PMID: 38951925 PMC: 11218093. DOI: 10.1186/s40168-024-01820-1.


C-reactive Protein: An Inflammatory Biomarker and a Predictor of Neurodegenerative Disease in Patients With Inflammatory Bowel Disease?.

Muresan S, Slevin M Cureus. 2024; 16(4):e59009.

PMID: 38665135 PMC: 11045161. DOI: 10.7759/cureus.59009.


Extracellular vesicles and their effect on vascular haemodynamics: a systematic review.

Cheung S, Chamley L, Barrett C, Lau S Hypertens Res. 2024; 47(6):1588-1606.

PMID: 38600279 PMC: 11150158. DOI: 10.1038/s41440-024-01659-x.


Exosomes-transferred LINC00668 Contributes to Thrombosis by Promoting NETs Formation in Inflammatory Bowel Disease.

Zhang L, Zheng B, Bai Y, Zhou J, Zhang X, Yang Y Adv Sci (Weinh). 2023; 10(28):e2300560.

PMID: 37590310 PMC: 10558653. DOI: 10.1002/advs.202300560.


References
1.
Koutroubakis I, Sfiridaki A, Tsiolakidou G, Coucoutsi C, Theodoropoulou A, Kouroumalis E . Plasma thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 levels in inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2008; 20(9):912-6. DOI: 10.1097/MEG.0b013e3282faa759. View

2.
Baumgart D, Carding S . Inflammatory bowel disease: cause and immunobiology. Lancet. 2007; 369(9573):1627-40. DOI: 10.1016/S0140-6736(07)60750-8. View

3.
Chamouard P, Desprez D, Hugel B, Kunzelmann C, Gidon-Jeangirard C, Lessard M . Circulating cell-derived microparticles in Crohn's disease. Dig Dis Sci. 2005; 50(3):574-80. DOI: 10.1007/s10620-005-2477-0. View

4.
Anthony A, Dhillon A, Pounder R, Wakefield A . Ulceration of the ileum in Crohn's disease: correlation with vascular anatomy. J Clin Pathol. 1998; 50(12):1013-7. PMC: 500383. DOI: 10.1136/jcp.50.12.1013. View

5.
Lebuffe G, Haddad E, Desreumaux P, Gambiez L, Colombel J, Vallet B . Impaired contractile response of mesenteric arteries in Crohn's disease. Aliment Pharmacol Ther. 2000; 14(10):1279-85. DOI: 10.1046/j.1365-2036.2000.00838.x. View